Bern, Berne, Switzerland
Curious, and active observer, I seek out challenges beyond the familiar, because that’s where innovation is, and where I have made the greatest difference for patients and the communities we serve. My early training at the renowned Hôpital Necker in Paris to my academic research at Uniklinik Freiburg, and over the past 12 years in biotech leadership at CSL, I have bridged the academic and industrial worlds to bring science to life. Fluent in French, German, and English, I have built and led highly efficient and agile international teams, developed new capabilities, including a nebulization platform and a gene therapy research unit, and driven programs from discovery to development, with the objective to fully support our customers (therapeutic area leads, functions and our patients). My work has led to over 26 high-impact publications (Nat. Biotech., Immunity, Science, New England Journal of Medicine, etc.), 2 IND-ready assets, one Phase II clinical program, and the start of several early research programs, reflecting both scientific excellence and translational success. I have also led or supported over ten strategic collaborations with leading academic and biotech partners across Europe and the US, demonstrating my ability to foster scientific partnerships while maintaining operational excellence. I am passionate about enabling innovation, with purpose, urgency, pragmatism, integrity, and collaboration.
I am accountable for driving strategic oversight and execution across multidisciplinary teams, ensuring evidence-based decisions and seamless project transitions from research to development. My role is instrumental in shaping project strategy, fostering global collaborations, and delivering innovative solutions in cardiovascular and renal therapeutics, directly impacting the advancement of scientific and clinical milestones. This role is similar to the one which I used to do along my managerial role, and which was called Project Scientific Coordinator. This new role is exciting as it offers the oversight of not only one project but a project portfolio.
PhD candidate, Project : Molecular and Functional Characterization of Autoimmune Lymphoproliferative Syndrome (ALPS) type II. French Institute of Health and Medical Research (INSERM), Unit 429, Necker Hospital, Paris, France. Advisors : Dr. Frédéric Rieux-Laucat (Ph.D)(mentor) & Prof. Alain Fischer (M.D., Ph.D)